LadRx Competitors

Delisted . USA . 
Stock . LadRx
LADXDelisted Stock  USD 2.37  0.14  6.28%   
LadRx competes with NovaBay Pharmaceuticals, InMed Pharmaceuticals, GeoVax Labs, Phio Pharmaceuticals, and Protara Therapeutics; as well as few others. The company conducts business under Healthcare sector and is part of Biotechnology industry. Analyzing LadRx competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of LadRx to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of LadRx competition on your existing holdings.
  
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of LadRx's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
2.372.372.37
Details
Intrinsic
Valuation
LowRealHigh
2.252.252.61
Details
Naive
Forecast
LowNextHigh
3.533.533.53
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.762.192.62
Details

LadRx Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between LadRx and its competitors represents the degree of relationship between the price movements of corresponding otcs. A correlation of about +1.0 implies that the price of LadRx and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of LadRx does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
TARA
+ 0.79
SGTX
MGTA
+ 0.76
MTCR
MGTA
+ 0.69
SGTX
TCON
+ 0.6
PHIO
STSA
+ 0.54
TARA
TARA
+ 0.53
MGTA
  
High negative correlations   
NBY
- 0.64
SGTX
TARA
- 0.54
NBY
MTCR
- 0.43
INM
STSA
- 0.41
PHIO
TARA
- 0.37
PHIO
TCON
- 0.36
TARA

Risk-Adjusted Indicators

There is a big difference between LadRx OTC Stock performing well and LadRx OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze LadRx's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
SGTX  14.93  6.21  0.73 (1.50) 6.43 
(22.18)
 12.46 
(14.07)
 442.39 
NBY  4.28  0.33  0.06 (2.76) 3.97 
(6.76)
 9.86 
(8.82)
 58.17 
INM  4.87 (0.11) 0.00 (0.08) 0.00 
 0.00 
 10.00 
(12.08)
 39.14 
GOVX  5.47  0.19  0.03 (0.13) 5.43 
(7.69)
 12.63 
(8.97)
 77.95 
PHIO  4.87 (0.83) 0.00 (0.73) 0.00 
 0.00 
 9.30 
(11.53)
 48.43 
MTCR  2.61  0.32  0.08  0.87  2.40 
(5.45)
 9.09 
(4.65)
 21.01 
MGTA  2.62  0.12  0.02 (0.29) 3.40 
(3.33)
 5.88 
(4.29)
 16.99 
TARA  5.57  1.95  0.39 (13.96) 3.77 
(7.85)
 13.00 
(6.48)
 78.24 
TCON  6.84 (1.82) 0.00  1.40  0.00 
 0.00 
 19.59 
(17.77)
 52.05 
STSA  3.39  0.51  0.12 (4.49) 3.54 
(4.82)
 5.71 
(7.79)
 70.12 
All Fundamental Data

LadRx Competitive Analysis

The better you understand LadRx competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, LadRx's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across LadRx's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
LADX SGTX NBY INM GOVX PHIO MTCR MGTA TARA TCON
 6.28 
 2.37 
LadRx
 1.54 
 21.11 
Sigilon
 6.00 
 0.53 
NovaBay
 6.28 
 4.40 
InMed
 1.29 
 2.29 
GeoVax
 1.15 
 1.76 
Phio
 0.00 
 0.49 
Metacrine
 3.80 
 0.82 
Magenta
 4.05 
 5.39 
Protara
 52.38 
 1.60 
TRACON
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Dangerous
Very risky
Dangerous
Somewhat reliable
Very steady
Very steady
Relatively risky
Very steady
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Very Weak
Weak
Weak
Very Weak
Very Weak
Very Weak
Good
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Dangerous
High
Very High
Very High
Low
Dangerous
Dangerous
Low
Dangerous
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Under Valued
Over Valued
Under Valued
Under Valued
Over Valued
Over Valued
Under Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Strong Buy
Not Available
Strong Buy
Buy
Not Available
Not Available
Strong Buy
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Not Rated
Strong Sell
Cautious Hold
Strong Sell
Strong Sell
Not Rated
Not Rated
Strong Sell
Not Rated
Current Ratio
1.83
2.77
2.59
3.52
9.51
6.48
22.29
10.22
28.94
1.17
Net Asset
8.73 M
87.28 M
9.03 M
11.82 M
9.28 M
9.36 M
79.99 M
146.65 M
78.95 M
10.11 M
Profit Margin
N/A
-1.71
-0.77
-1.67
N/A
N/A
N/A
N/A
N/A
0.14
EBITDA
(5.97 M)
(41.27 M)
(4.8 M)
(7.06 M)
(26.67 M)
(10.64 M)
(60.71 M)
(78.98 M)
(43.27 M)
(6.88 M)
Current Valuation
7.5 M
28.99 M
3.08 M
(1.55 M)
20.19 M
(6.6 M)
(23.98 M)
(32.66 M)
107.53 M
(2.64 M)
Price To Book
8.48
0.25
2.43
0.35
2.54
0.38
0.4
0.54
2.25
11.83
Operating Margin
N/A
-1.75
-0.43
-1.57
-16.84
N/A
N/A
N/A
N/A
-32.12
Retained Earnings
N/A
(256.8 M)
(174.85 M)
(109.08 M)
(104.36 M)
(139.21 M)
N/A
(402.03 M)
(200.38 M)
(240.5 M)
Current Asset
N/A
N/A
4.53 M
N/A
1.24 M
9.23 M
N/A
33.34 M
N/A
53.31 M
Beta
2.07
4.12
0.73
0.71
3.11
1.47
-0.73
2.12
1.79
1.24
Number Of Employees
3
62
24
13
17
8
10
67
26
17
Shares Outstanding
45.04 M
2.5 M
4.89 M
718.08 K
9.44 M
860.72 K
42.57 M
60.66 M
34.32 M
2.68 M
Cash Flow From Operations
(12.31 M)
(51.47 M)
(4.13 M)
(6.99 M)
(25.17 M)
(10.75 M)
(47.16 M)
(67.09 M)
(37.56 M)
3.68 M
Annual Yield
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Debt
322.33 K
28.06 M
2.74 M
962.66 K
3.52 M
35 K
13.3 M
29.96 M
5.47 M
968 K
Return On Equity
-1.64
-0.76
-2.64
-0.72
-3.62
-1.27
-0.91
-0.65
-0.46
-12.77
Z Score
7.8
-3.73
N/A
N/A
N/A
N/A
0.6
-3.88
N/A
N/A
Return On Asset
-0.34
-0.24
-0.39
-0.39
-1.34
-0.61
-0.37
-0.29
-0.28
-0.2
Number Of Shares Shorted
294.31 K
8.23 K
73.17 K
12.75 K
479.76 K
48.12 K
87.42 K
383.03 K
3.02 M
166.13 K
Book Value Per Share
-0.007
10.97
0.22
1.03
2.92
7.4
0.87
1.24
6.01
-0.66
Current Liabilities
N/A
N/A
4.63 M
N/A
126.99 K
2.17 M
N/A
3.39 M
N/A
14.18 M
Total Asset
8.73 M
87.28 M
9.03 M
11.82 M
9.28 M
9.36 M
79.99 M
146.65 M
78.95 M
10.11 M
Debt To Equity
0.14
0.61
0.14
0.063
0.009
0.013
0.33
0.25
0.046
0.35
Short Ratio
1.96
0.11
0.07
0.12
0.35
0.5
0.21
1.38
14.46
0.95
Target Price
N/A
47.33
3.73
20.0
14.6
36.0
0.5
1.0
26.4
30.5
Shares Owned By Institutions
9.3
54.33
2.58
9.5
10.82
2.07
35.96
62.63
51.1
11.42
Market Capitalization
4.32 M
56.22 M
2.59 M
2.97 M
21.61 M
2.02 M
20.94 M
45.14 M
184.98 M
3.83 M
Price To Earning
N/A
N/A
-5.43
N/A
-1.25
-0.8
N/A
-1.63
N/A
-1.51
Price To Earnings To Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Price To Sales
34.48
0.87
0.2
0.65
71.87
48.01
N/A
N/A
N/A
0.45
Net Income
(13.18 M)
(43.56 M)
(9.64 M)
(7.68 M)
(25.97 M)
(10.83 M)
(62.21 M)
(76.46 M)
(40.42 M)
(3.59 M)
Earnings Per Share
N/A
-14.83
-74.61
230.4
-8.39
-14.81
-1.93
-1.11
-2.74
106.4
Shares Owned By Insiders
9.76
8.69
0.02
0.61
0.52
5.89
12.29
2.23
6.12
2.2
Revenue
N/A
12.94 M
14.73 M
4.6 M
N/A
N/A
N/A
N/A
N/A
12.04 M
Working Capital
N/A
43.42 M
2.88 M
6.72 M
4.37 M
7.69 M
N/A
101.05 M
62.56 M
(1.09 M)
Cash And Equivalents
4.11 M
88.21 M
5.36 M
9.35 M
30.9 M
18.02 M
55.53 M
128.28 M
98.46 M
13.58 M
Cash Per Share
0.09
2.72
0.07
9.98
1.25
1.32
1.3
2.13
8.74
0.63
Gross Profit
N/A
(24.69 M)
5.64 M
1.4 M
81.53 K
(7.01 M)
(45.47 M)
N/A
N/A
(13.89 M)
Day Typical Price
2.32
21.23
0.52
4.35
2.29
1.71
0.48
0.81
5.27
1.39
Accumulation Distribution
0.0591
0.0364
33844.02
3319.83
51222.64
45753.68
0.17
0.0482
74248.21
0.5
Market Facilitation Index
0.14
0.79
N/A
0.0
N/A
0.0
0.09
0.04
N/A
0.86
Daily Balance Of Power
1.0
(0.42)
1.0
0.7027
(0.16)
0.0833
N/A
0.75
0.525
0.6395
Period Momentum Indicator
0.14
(0.33)
0.03
0.26
(0.03)
0.02
N/A
0.03
0.21
0.55
Rate Of Daily Change
1.06
0.98
1.06
1.06
0.99
1.01
1.0
1.04
1.04
1.52
Day Median Price
2.3
21.3
0.52
4.32
2.29
1.69
0.48
0.81
5.21
1.28
Price Action Indicator
0.14
(0.35)
0.03
0.21
(0.01)
0.08
0.015
0.025
0.28
0.6
Relative Strength Index
38.32
76.02
40.68
54.07
46.6
49.34
N/A
58.21
68.1
38.83
Coefficient Of Variation
310051.32
890.59
2277.16
(8,828)
5667.23
(889.98)
1222.97
2966.12
533.59
(610.48)
Mean Deviation
10.61
14.93
4.28
4.87
5.47
4.87
2.61
2.62
5.57
6.84
Jensen Alpha
0.0105
6.21
0.3328
(0.11)
0.192
(0.83)
0.3175
0.1231
1.95
(1.82)
Total Risk Alpha
(0.48)
4.59
0.1132
(0.29)
(0.11)
(1.00)
0.2108
0.0111
1.66
(2.16)
Sortino Ratio
(0)
0.727
0.0641
N/A
0.0255
N/A
0.0808
0.0219
0.3892
N/A
Downside Variance
338.86
70.37
23.06
N/A
31.18
N/A
14.12
17.78
24.5
N/A
Standard Deviation
16.98
54.6
7.74
7.08
9.89
7.06
4.11
3.69
10.45
11.21
Kurtosis
3.9
63.02
22.04
1.81
22.08
4.61
5.08
3.46
28.0
5.52
Potential Upside
21.39
12.46
9.86
10.0
12.63
9.3
9.09
5.88
13.0
19.59
Treynor Ratio
0.0067
(1.50)
(2.76)
(0.08)
(0.13)
(0.73)
0.8736
(0.29)
(13.96)
1.4
Maximum Drawdown
109.99
442.39
58.17
39.14
77.95
48.43
21.01
16.99
78.24
52.05
Variance
288.35
2980.94
59.98
50.12
97.85
49.84
16.86
13.63
109.23
125.56
Market Risk Adjusted Performance
0.0167
(1.49)
(2.75)
(0.07)
(0.12)
(0.72)
0.8836
(0.28)
(13.95)
1.41
Risk Adjusted Performance
0.0098
0.0988
0.0438
(0.000093)
0.0232
(0.08)
0.0729
0.0346
0.1577
(0.12)
Skewness
(0.11)
7.85
3.89
0.2759
3.87
(1.03)
1.61
(0.42)
4.48
(0.27)
Semi Deviation
15.6
6.43
3.97
N/A
5.43
N/A
2.4
3.4
3.77
N/A
Information Ratio
(0)
0.1117
0.0398
(0.02)
0.0144
(0.12)
0.0739
0.025
0.1843
(0.17)
Value At Risk
(29.38)
(14.07)
(8.82)
(12.08)
(8.97)
(11.53)
(4.65)
(4.29)
(6.48)
(17.77)
Expected Short fall
(13.48)
(22.18)
(6.76)
N/A
(7.69)
N/A
(5.45)
(3.33)
(7.85)
N/A
Downside Deviation
18.41
8.39
4.8
N/A
5.58
N/A
3.76
4.22
4.95
N/A
Semi Variance
243.28
41.33
15.74
N/A
29.48
N/A
5.76
11.57
14.23
N/A

LadRx Competition Performance Charts

Five steps to successful analysis of LadRx Competition

LadRx's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by LadRx in relation to its competition. LadRx's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of LadRx in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact LadRx's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to LadRx, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your LadRx position

In addition to having LadRx in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Manufacturing Thematic Idea Now

Manufacturing
Manufacturing Theme
Companies that provide goods across residential, commercial and industrial construction such as machinery, tools, or lumber production. The Manufacturing theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Manufacturing Theme or any other thematic opportunities.
View All  Next Launch
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
Note that the LadRx information on this page should be used as a complementary analysis to other LadRx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Consideration for investing in LadRx OTC Stock

If you are still planning to invest in LadRx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LadRx's history and understand the potential risks before investing.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY